Clinical Trial Update: Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of FolateScan (Technetium Tc 99m EC20) in subjects with suspected metastatic renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• FolateScan

Snippet

Sponsor: Endocyte | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED